PMID- 26640385 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20151207 LR - 20220321 IS - 1178-6930 (Print) IS - 1178-6930 (Electronic) IS - 1178-6930 (Linking) VI - 8 DP - 2015 TI - High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma. PG - 3449-55 LID - 10.2147/OTT.S92862 [doi] AB - OBJECTIVE: The disheveled, Egl-10, and pleckstrin (DEP) domain containing mammalian target of rapamycin (mTOR)-interacting protein (DEPTOR) is a binding protein containing mTOR complex 1 (mTORC1), mTOR complex 2 (mTORC2), and an endogenous mTOR inhibitor. DEPTOR shows abnormal expressions in numerous types of solid tumors. However, how DEP-TOR is expressed in esophageal squamous cell carcinoma (ESCC) remains elusive. METHODS: The expression of DEPTOR in 220 cases of ESCC and non-cancerous adjacent tissues was detected by immunohistochemistry. DEPTOR levels in ESCC and paired normal tissue were quantified using reverse transcription-polymerase chain reaction and Western blot analysis to verify the immunohistochemical results. The relationship between DEPTOR expression and the clinicopathological features of ESCC was analyzed based on the results of immunohistochemistry. Finally, we analyzed the relationship between DEPTOR expression and the prognosis of patients with ESCC. RESULTS: Immunohistochemical staining showed that the expression rate of DEPTOR in ESCC tissues was significantly increased. DEPTOR mRNA and protein expression was significantly higher in ESCC tissues than in normal adjacent esophageal squamous tissues. High DEPTOR expression was significantly correlated with regional lymph node status in the TNM stage of patients with ESCC. Kaplan-Meier survival curves showed that the rate of overall survival was significantly lower in patients with high DEPTOR expression than in those with low DEPTOR expression. Additionally, high DEPTOR expression was an independent prognostic predictor for ESCC patients. CONCLUSION: High DEPTOR expression is an independent prognostic biomarker indicating a worse prognosis for patients with ESCC. FAU - Liu, Nan-Bo AU - Liu NB AD - Department of Thoracic Surgery, Southern Medical University, Guangzhou, People's Republic of China. FAU - Zhang, Jun-Hua AU - Zhang JH AD - Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China. FAU - Liu, Yu-Fan AU - Liu YF AD - Department of Thoracic Surgery, Southern Medical University, Guangzhou, People's Republic of China. FAU - Li, Jun AU - Li J AD - Department of Thoracic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, People's Republic of China. FAU - Zhang, Zhen-Zhong AU - Zhang ZZ AD - Department of Thoracic Surgery, Southern Medical University, Guangzhou, People's Republic of China. FAU - Li, Ji-Wei AU - Li JW AD - Department of Thoracic Surgery, Southern Medical University, Guangzhou, People's Republic of China. FAU - Liu, Wen-Yue AU - Liu WY AD - Department of Thoracic Surgery, Southern Medical University, Guangzhou, People's Republic of China. FAU - Huang, Chen AU - Huang C AD - Department of Thoracic Surgery, Southern Medical University, Guangzhou, People's Republic of China ; Department of Thoracic Surgery, Fujian Provincial Hospital, Fuzhou, People's Republic of China. FAU - Shen, Tao AU - Shen T AD - Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen, People's Republic of China. FAU - Gu, Cheng-Wei AU - Gu CW AD - Department of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, People's Republic of China. FAU - Gao, Dong-Yun AU - Gao DY AD - Department of Oncology, Dongtai People's Hospital, Dongtai, People's Republic of China. FAU - Wu, Xia AU - Wu X AD - Department of Breast Cancer, Affiliated Hospital, Academy of Military Medical Sciences, Beijing, People's Republic of China. FAU - Wu, Xu AU - Wu X AD - Department of Thoracic Surgery, Southern Medical University, Guangzhou, People's Republic of China. LA - eng PT - Journal Article DEP - 20151119 PL - New Zealand TA - Onco Targets Ther JT - OncoTargets and therapy JID - 101514322 PMC - PMC4657798 OTO - NOTNLM OT - DEPTOR OT - ESCC OT - prognosis EDAT- 2015/12/08 06:00 MHDA- 2015/12/08 06:01 PMCR- 2015/11/19 CRDT- 2015/12/08 06:00 PHST- 2015/12/08 06:00 [entrez] PHST- 2015/12/08 06:00 [pubmed] PHST- 2015/12/08 06:01 [medline] PHST- 2015/11/19 00:00 [pmc-release] AID - ott-8-3449 [pii] AID - 10.2147/OTT.S92862 [doi] PST - epublish SO - Onco Targets Ther. 2015 Nov 19;8:3449-55. doi: 10.2147/OTT.S92862. eCollection 2015.